跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
UCERIS - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
UCERIS
Authorized
STANDARD
UCERIS
bausch health, canada inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
96fc5c03d957e353
Company
bausch health, canada inc.
Type
Standard
Approval Details
Approval Id
96fc5c03d957e353
Drug Approval Canada Name
UCERIS
Product Name
UCERIS
Status
Marketed
Status Date
2023-09-18
Original Market Date
2023-09-18
Din
02498057
Drug Class
Human
Dosage Form
Foam
Route Of Administration
Rectal
Schedule
Prescription
Ahfs
56:36.00
Atc Original
A07EA06 BUDESONIDE
Atc Name
a 07 ea 06
Aig Number
0116807014
Company Name
bausch health, canada inc.
Company Address
2150 Boul. St-Elzear Ouest, Laval, Quebec, Canada, H7L 4A8
Active Ingredients
BUDESONIDE
2 MG / ACT
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
96fc5c03d957e353
Type
Standard
Back to Health Canada Approvals